Levo-C

Carbidopa/Levodopa, the active ingredient in Levo‑C, is an antiparkinson agent presented as an oral tablet for oral use. The combination increases central dopamine availability, helping to control tremor, rigidity and bradykinesia in adult patients with Parkinson's disease and related Parkinsonian syndromes.

GNH USA supplies Levo‑C as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levo‑C, a carbidopa/levodopa formulation, is employed in the management of Parkinsonian movement disorders.

- Parkinson's disease: improves motor function and reduces OFF periods. - Parkinsonian syndrome: alleviates rigidity, tremor and bradykinesia. - Levodopa‑responsive motor fluctuations: decreases frequency and severity of motor fluctuations. - Resting tremor: reduces amplitude of tremor.

Levo‑C may cause a range of adverse reactions, which are classified by frequency.

Common Side Effects: - Nausea - Vomiting - Orthostatic hypotension - Dizziness - Headache - Insomnia

Serious or Rare Side Effects: - Dyskinesia (involuntary movements) - Hallucinations or psychosis - Severe hypotension or syncope - Neuroleptic malignant syndrome - Cardiac arrhythmias - Severe allergic reactions (e.g., angioedema, anaphylaxis)

When prescribing Levo‑C, clinicians should observe several precautionary measures to ensure safe use.

- Blood pressure monitoring: watch for orthostatic drops, especially after dose initiation. - Renal/hepatic function: adjust therapy in patients with significant impairment. - Abrupt discontinuation: avoid sudden stop to prevent withdrawal syndrome. - Psychiatric history: monitor for hallucinations or mood changes. - Elderly patients: start with low dose and titrate slowly. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Levo‑C can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Pyridoxine (vitamin B6) at high doses: reduces levodopa efficacy. - Antipsychotics that block dopamine receptors: diminish therapeutic effect. - High‑protein meals: may impair levodopa absorption. - Iron or calcium supplements taken simultaneously: decrease levodopa bioavailability.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: additive blood‑pressure lowering. - Other dopaminergic drugs (e.g., dopamine agonists): may increase dyskinesia risk. - SSRIs or SNRIs: monitor for serotonin syndrome. - Diuretics: watch for electrolyte disturbances affecting blood pressure. - Anticholinergic medications: may mask some side effects.